Topics

High-grade gliomas | Treatment | Clinical trials

Home > Publications > Topics > High-grade gliomas > Treatment > Clinical trials

OVERALL MANAGEMENT

□ BRAIN EDEMA MANAGEMENT

□ DRUG SENSITIVITY TESTING

□ NEOADJUVANT THERAPIES

CHEMOTHERAPY

□ BXQ-350

□ CISPLATIN

□ EVEROLIMUS

□ IRINOTECAN

□ TEMOZOLOMIDE

IMMUNOTHERAPY

□ CAR-T-Cells

□ INTERLEUKINS

□ VIRUSES

PHARMACOTHERAPY

□ ACETAZOLAMIDE

□ MEBENDAZOLE

RADIOTHERAPY

□ BRACHYTHERAPY

□ MARGINS

□ RE-IRRADIATION

SUPPORTIVE CARE

□ PSYCHOSOCIAL DISTRESS

TARGETED THERAPY

□ APATINIB

□ BEVACIZUMAB

□ CAMRELIZUMAB

□ IPILIMUMAB

□ LENVATINIB

□ NILOTINIB

□ NIVOLUMAB

□ SM-1

□ SYHA1813

□ TARG RADIONUCLIDE THERAPY

□ TERAMEPROCOL

□ TG02